Translational control of polyamine metabolism by CNBP is required for Drosophila locomotor function

  1. Sonia Coni
  2. Federica A Falconio
  3. Marta Marzullo
  4. Marzia Munafò
  5. Benedetta Zuliani
  6. Federica Mosti
  7. Alessandro Fatica
  8. Zaira Ianniello
  9. Rosa Bordone
  10. Alberto Macone
  11. Enzo Agostinelli
  12. Alessia Perna
  13. Tanja Matkovic
  14. Stephan Sigrist
  15. Gabriella Silvestri
  16. Gianluca Canettieri  Is a corresponding author
  17. Laura Ciapponi  Is a corresponding author
  1. Department of Molecular Medicine, Sapienza University of Rome, Italy
  2. Department of Biology and Biotechnologies, Sapienza University of Rome, Italy
  3. Department of Life Sciences Imperial College London South Kensington campus, United Kingdom
  4. IBPM CNR c/o Department of Biology and Biotechnology, Sapienza University of Rome, Italy
  5. European Molecular Biology Laboratory (EMBL) Epigenetics & Neurobiology Unit, Campus Adriano Buzzati-Traverso, Italy
  6. Department of Neurobiology, Duke University Medical Center, United States
  7. Department of Biochemical Sciences, Sapienza University of Rome, Italy
  8. Department of Sensory Organs, Sapienza University of Rome, Policlinico Umberto I, Italy
  9. International Polyamines Foundation ‘ETS-ONLUS’, Italy
  10. Department of Neuroscience, Fondazione Policlinico Gemelli IRCCS, University Cattolica del S. Cuore, Italy
  11. Freie Universität Berlin, Institute for Biology and Genetics, Germany
  12. Department of Scienze dell’Invecchiamento, Neurologiche, Ortopediche e della testa-Collo; UOC Neurologia, Fondazione Policlinico Universitario ‘A. Gemelli’ IRCCS, Italy
  13. Pasteur Institute, Fondazione Cenci-Bolognetti, Italy
8 figures, 2 tables and 4 additional files

Figures

Figure 1 with 4 supplements
Specific dCNBP depletion in muscle tissues results in locomotor defects.

(A) Locomotion activity in escapers adult flies expressing (B) UAS-dCNBPRNAi-16283; UAS-dCNBPRNAi-16284 (2XdCNBPRNAi) driven by the myocyte enhancer factor 2 (Mef2)-GAL4 at 25°C, compared to control flies (no UAS). Fly movements were recorded (Figure 1—video 1, 2, 3) and then analyzed by the animal tracker ImageJ plugin, to quantify both fly speed (average, cm/s) and distance covered in 1 min (Gulyás et al., 2016). (C) Climbing activity defects in adult flies expressing 2XdCNBPRNAi driven by the mhc-GAL4 at 29°C. The locomotion activity was measured by the Drosophila activity monitoring (DAM) system, as the number of climbing events in 30 min ≥ 80 males tested for each genotype. On the left, climbing performance of control flies (no UAS) or dCNBP-depleted flies (2XdCNBPRNAi) 7 days after eclosion represented as the average of climbing events (CEs) in 30 min (error bars represent SEM; ****p<0.0001, Mann-Whitney-Wilcoxon test). On the right, quantitative grouping of climbing performances in four different classes. Classes 1–20 (white area) and 20–50 (light gray area) CEs are highly represented in RNAi flies (2XdCNBPRNAi), while classes 50–100 CEs (dark gray area) are more frequent in control flies (no UAS). Only control flies have the ability to perform more than 100 CEs in 30 min (black area). Full data in Figure 1—source data 1. (D) Box plot representation of the distribution of peristaltic contraction rates performed in 1 min by control (no UAS) or UAS-dCNBPRNAi-16283; UAS-dCNBPRNAi-16284 (2XdCNBPRNAi) third instar larvae under the control of either c179GAL4 or 24BGAL4 driver at 25°C (****p<0.0001, t-test); ≥10 larvae tested for each genotype in at least three independent experiments. Full data in Figure 1—source data 1. (E) Box plot representation of the distribution of peristaltic contraction rates performed by control (wild-type [WT]) or cnbpk mutant second instar larvae in 1 min; ≥30 larvae tested for each genotype (p < 0.0001, Mann-Whitney-Wilcoxon test). In (C and D) the line inside the box indicates the median for each genotype and box boundaries represent the first and third quartiles; whiskers are min and max in the 1.5 interquartile range. Full data in Figure 1—source data 1. (F) Immunoblot showing the levels of dCNBP in extract obtained from cnbpk mutant second instar or from WT control larvae with the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Actin, loading control. A.U., arbitrary unit.

Figure 1—figure supplement 1
dCNBP knockdown efficacy in absence of phenotype.

Immunoblot showing the levels of dCNBP in extract obtained from larval brains or adult heads of UAS-dCNBPRNAi-16283; UAS-dCNBPRNAi-16284 (2XdCNBPRNAi) individuals, where the knockdown is driven by either the n-syb or the elav GAL4 drivers at 25°C, compared to control (no UAS). On the right a graph showing the corresponding band quantification, normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Tubulin, loading control. A.U., arbitrary unit.

Figure 1—video 1
Example of locomotor movement of a control adult fly (myocyte enhancer factor 2 [Mef2]-GAL4 > no UAS at 25°C).
Figure 1—video 2
Example of locomotor defects of a dCNBP-interfered adult fly (myocyte enhancer factor 2 [Mef2]-GAL4 > UAS-dCNBPRNAi-16283; UAS-dCNBPRNAi-16284 at 25°C).
Figure 1—video 3
Second example of locomotor defects of a dCNBP-interfered adult fly (myocyte enhancer factor 2 [Mef2]-GAL4>UAS-dCNBPRNAi-16283; UAS-dCNBPRNAi-16284at25°C).
Cellular nucleic acid-binding protein (CNBP) overexpression rescues the locomotion phenotype induced by muscular dCNBP depletion.

dCNBP knockdown in embryonic mesoderm causes a significant reduction of larval peristaltic waves rescued by the expression of either dCNBP or hCNBP transgenes (25°C). (A) Box plot representation of the distribution of peristaltic contraction rates performed by third instar larvae of the following genotypes: only c179GAL4 driver (no UAS), c179GAL4>UAS-dCNBPRNAi-16283; UAS-dCNBPRNAi-16284 (2XdCNBPRNAi), c179GAL4>2XdCNBPRNAi + UAS-dCNBP-3HA-res (a dCNBP-3HA transgene resistant to 2XUASdCNBP-induced RNAi), c179GAL4>2XdCNBPRNAi + UAS-hCNBP-FLAG. The line inside the box indicates the median for each genotype and box boundaries represent the first and third quartiles; whiskers are min and max in the 1.5 interquartile range (****p<0.0001, Kruskal-Wallis with post hoc Dunn’s test); ≥10 larvae tested for each genotype in at least three independent experiments. Full data in Figure 2—source data 1. (B) The expression levels of both UAS-dCNBP-3HA-res and UAS-hCNBP-FLAG were analyzed by immunoblotting using antibodies against either the HA or the FLAG tag, compared to controls (no UAS). Bands were quantified by IMAGE J 1.50i and normalized on the loading control (quantification data in source data for western blot [WB] quantification). Tubulin, loading control. A.U., arbitrary unit.

Figure 3 with 1 supplement
CNBP regulates the ornithine decarboxylase (ODC)/polyamine axis.

Levels of both Odc and putrescine are significantly reduced in dCNBP-depleted larvae compared to wild-type controls. (A) Immunoblot showing the levels of both dCNBP and dOdc in extract obtained from tubGAL4>2XdCNBPRNAi third instar larvae compared to control (no UAS), with the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Actin, loading control. A.U., arbitrary unit. (B) Columns represent the fold difference of putrescine content in third instar larvae bearing the c179GAL4 driver alone (no UAS) or in combination with double copy dCNBP RNAi-expressing larvae (UAS-dCNBPRNAi-16283; UAS-dCNBPRNAi-16284, named 2XdCNBPRNAi). Error bars represent SEM; ***p>0.001, ** p>0.002, in unpaired t-test. A pool of 10 larvae has been tested for each genotype in three independent experiments. Full data in Figure 3—source data 1.

Figure 3—figure supplement 1
Larval locomotor defect observed in cnbpk mutants correlates with the reduction of ornithine decarboxylase (Odc) protein and polyamine levels.

Levels ofOdc protein and polyamine are significantly reduced in dCNBP mutant larvae compared to wild-type (WT) controls. (A) Immunoblot showing the levels of both dCNBP and dOdc in extract obtained from WT and cnbpk mutant second instar larvae, with the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Actin, loading control. (B) Columns represent the fold difference of putrescine content in second instar larvae of cnbpk mutant compared to controls (WT). Error bars represent SEM; **p>0.002, t-test. A pool of 10 larvae has been tested for each genotype in three independent experiments. Full data in Figure 3—source data 1.

Figure 4 with 1 supplement
Ornithine decarboxylase (Odc) depletion phenocopies the dCNBP locomotor defects.

Box plot representation of the distribution of peristaltic contraction rates performed by third instar larvae of the reported genotypes in 1 min. (A) c179GAL4>no UAS, UAS-Odc1RNAi-30039, UAS-Odc2RNAi-10459, UAS-Odc2RNAi-10459; UAS-Odc1RNAi-30039, or UAS-dCNBPRNAi-16283; UAS-dCNBPRNAi-16284. In the graph legend UAS in transgenic RNAi lines is omitted for simplicity. (B) Controls (wild type) and dOdc1MI10996 mutant larvae. (C) Controls fed with standard fly food (wild type) or after DFMO treatment (5 mM/day; wild type + DFMO). The line inside the box indicates the median for each genotype and box boundaries represent the first and third quartiles; whiskers are min and max in the 1.5 interquartile range (**p<0.001; ****p<0.0001; ns, not significant, Kruskal-Wallis with post hoc Dunn’s test for multiple comparison or Mann-Whitney-Wilcoxon test for); ≥10 larvae tested for each genotype in at least three independent experiments. All full data in Figure 4—source data 1.

Figure 4—source data 1

Larval movement measurements as shown in Figure 4A-C and putrescine content quantification as shown in Figure 4—figure supplement 1.

https://cdn.elifesciences.org/articles/69269/elife-69269-fig4-data1-v1.xlsx
Figure 4—figure supplement 1
Larval locomotor defect observed as a consequence of ornithine decarboxylase (Odc) depletion correlates with the reduction of polyamine levels.

Columns represent the fold difference of putrescine content in third instar larvae of the following genotypes: only c179GAL4 driver (no UAS), c179GAL4>UAS-dOdc1RNAi-30039 (dOdc1RNAi), c179GAL4>UAS-dOdc2RNAi-10459 (dOdc2RNAi), c179GAL4>UAS-dOdc2RNAi-10459; UAS-dOdc1RNAi-30039 (dOdc1+2RNAi) (error bars represent SEM; ***p>0.001 with respect to the no UAS control, t-test). A pool of 10 larvae has been tested for each genotype in at least three independent experiments. Full data in Figure 4—source data 1.

Figure 5 with 1 supplement
Polyamine metabolism is impaired also in myotonic dystrophy type 2 (DM2) muscles.

Cellular nucleic acid-binding protein (CNBP) and ornithine decarboxylase (ODC) content correlates with polyamine levels in muscle cells from DM2 patients. (A) Immunoblot showing the levels of both human CNBP (hCNBP) and human ODC (hODC) proteins in three DM2 or control muscle cells, with the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Vinculin, loading control. A.U., arbitrary unit. (B) Columns represent putrescine content in muscle cells obtained from four DM2 patients (CTRL) or from four healthy individuals (DM2), expressed in ng/mg of tissue. Error bars represent SEM; **p>0.001, in unpaired t-test. Full data in Figure 5—source data 1.

Figure 5—figure supplement 1
Expression levels of dCNBP are not affected by the expression of CCUG-expanded repeat RNA.

Immunoblot showing the levels of dCNBP in larval extract obtained from controls (no UAS) or UAS-(CCTG)200, UAS-(CCTG)475, UAS-(CCTG)525 driven by the c179GAL4 driver, with the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Tubulin, loading control. A.U., arbitrary unit. A pool of 10 larvae has been tested for each genotype in at least two independent experiments.

Figure 6 with 4 supplements
dCNBP controls polyamine metabolism through the binding and the translational control of dOdc mRNA.

(A) dOdc1 mRNA levels (qPCR), normalized with the housekeeping RPL11 mRNA third instar larvae bearing c179GAL4 driver alone (no UAS) or in combination with UAS-dCNBPRNAi-16283; UAS-dCNBPRNAi-16284 (2XdCNBPRNAi). ns, not significant in unpaired t-test. Dots correspond to four independent biological replicates; bars indicate the mean and SEM. (B) Cellular nucleic acid-binding protein (CNBP) binds dOdc1 mRNA. qRT-PCR analysis on mRNAs immunoprecipitated by anti-dCNBP antibody or control IgG antisera in S2 cells extracts (left graph), or in dCNBP-depleted (2XdCNBPRNAi) or not (no UAS) larval extracts (right graph). The results are indicated as fold difference, relative to IgG. Error bars represent SEM of three independent experiments; *p < 0.05, in t-test. The presence of dCNBP in c179GAL4>2XUASdCNBPRNAi or control (no UAS) larval carcasses was analyzed by western blotting (right). Tubulin, loading control. (C) Representative polysome profiles (of at least three independent experiments) of dCNBP-deficient (dCNBPRNAi) or control (CTRL) S2 cells. Cytoplasmic lysates were fractionated on 15–50% sucrose gradients. (D) qPCR analysis of dOdc1 mRNA loaded in the different polysome fractions, GADPH was used to normalize the values. (*p < 0.05, t-test. Error bars represent SEM of experiments performed in quadruplicates and repeated at least three times.) The presence of dCNBP in interfered or not interfered S2 cells was analyzed by western blotting (right). Tubulin, loading control. All full data in Figure 6—source data 1.

Figure 6—figure supplement 1
dCNBP does not control polyamine metabolism through dOdc1 internal ribosome entry site (IRES)-dependent translation.

(A) Schematic representation of the bicistronic CMV-renilla-TAA/dOdc1-IRES-firefly luciferase (dOdc1-luc) vector (top). The renilla ORF is translated via conventional cap-dependent mechanism, whereas translation of the luciferase ORF is controlled by the dOdc1 5’UTR sequence. IRES activity of dOdc1-luc which is not significantly modulated by dCNBP overexpression compared to the empty vector (bottom). Columns represent the fold changes of luciferase activity, normalized to the renilla expression. Error bars represent SEM; ns: no significant with Student’s t-test, of three independent experiments. (B) Schematic representation of a bicistronic CMV-renilla-TAA/hODC-IRES-firefly luciferase (hODC-luc) vector (top). IRES activity of hODC-luc which is significantly modulated by both dCNBP or hCNBP overexpression, compared to the empty vector (bottom). Columns represent the fold changes of luciferase activity, normalized to the renilla expression. Error bars represent SEM; p<0.05 with Student’s t-test, of three independent experiments. All full data in Figure 6—source data 1.

Figure 6—figure supplement 2
In silico prediction of putative cellular nucleic acid-binding protein (CNBP) binding sites on the dOdc1 mRNA by RBPmap.

The dOdc1 transcript (FBtr0088863) was uploaded to the RBPmap web server for mapping binding sites. As criteria Drosophila genome, UGGAGNW consensus motif and high stringency level were used (Paz et al., 2014; http://rbpmap.technion.ac.il).

Figure 6—figure supplement 3
Efficiency of dCNBP silencing.

Quantification by IMAGE J 1.50i of the levels of dCNBP in extracts (A) obtained from control larvae (no UAS) or from larvae where the UAS-dCNBPRNAi-16283; UAS-dCNBPRNAi-16284 constructs (2XdCNBPRNAi) are driven by the c179GAL4 driver (from the immunoblot shown in Figure 6B); or in extracts (B) obtained from untreated S2 cells (CTRL) or from S2 cells CNBP-interfered (dCNBPRNAi; from the immunoblot shown in Figure 6D). A.U., arbitrary unit. Quantification data in source data for western blot [WB] quantification.

Figure 6—figure supplement 4
Cellular nucleic acid-binding protein (CNBP) promotes translation of dOdc mRNA.

Effect of human CNBP (hCNBP) depletion on both dOdc protein expression and mRNA level in 293T human cells. (A) Immunoblot showing a direct correlation of hCNBP depletion with a strong reduction of dOdc protein levels, with the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Actin, loading control. A.U., arbitrary unit. (B) dOdc1 mRNA levels (qPCR), normalized with the GFP mRNA levels. Error bars represent SEM of three independent experiments; ns, not significant in unpaired t-test. Full data in Figure 6—source data 1.

Figure 7 with 4 supplements
Odc and polyamine are responsible for the CNBP-dependent locomotor phenotype.

(A–B) Rescue of locomotor phenotype in both dCNBP-depleted larvae (A) and dCNBP mutant larvae (B) by 1 mM putrescine feeding at 29°C. Box plot representation of the distribution of peristaltic contraction rates performed by the following genotypes: (A) c179GAL4 driving no UAS or UAS-dCNBPRNAi-16283; UAS-dCNBPRNAi-16284 (2XdCNBPRNAi) with (1 mM put) or without (no put) putrescine. Note how putrescine feeding of interfered individuals results also in a higher stage of pupal development with respect to individuals not treated (photo in A). (B) Control (wild-type) or cnbpk larvae with (1 mM put) or without (no put) putrescine. (****p<0.0001; ns, not significant, Kruskal-Wallis with post hoc Dunn’s test). (C) Rescue of locomotor defects in dCNBP-depleted larvae by dOdc1 overexpression under the control of either Mef2 or c179GAL4 driver. Box plot representation of the distribution of peristaltic contraction rates performed by the following genotypes: Mef2GAL4 or c179GAL4 (no UAS), Mef2GAL4 or c179GAL4>2XdCNBPRNAi, Mef2GAL4 or c179GAL4>2XdCNBPRNAi + dOdc1 (UASdCNBPRNAi-16283; Mef2GAL4/UASdCNBPRNAi-16284; UASdOdc1/TM6B or UASdCNBPRNAi-16283; c179GAL4/UASdCNBPRNAi-16284; UAS dOdc1/+). (A–B–C) The line inside the box indicates the median for each genotype and box boundaries represent the first and third quartiles; whiskers are min and max in the 1.5 interquartile range (****p<0.0001; ns, not significant, Kruskal-Wallis with post hoc Dunn’s test); ≥10 larvae tested for each genotype in at least three independent experiments. (D) Mutants for dystrophin (Dysdet-1) present larval locomotor abnormalities that cannot be rescued by feeding larvae with 1 mM putrescine. Box plot representation of the distribution of peristaltic contraction rates performed by Dysdel-1 mutant larvae fed with or without putrescine (+1 mM put) with respect to wild-type control. The line inside the box indicates the median for each genotype and box boundaries represent the first and third quartiles; whiskers are min and max in the 1.5 interquartile range (ns, not significant, ****p<0.0001, Kruskal-Wallis with post hoc Dunn’s test); ≥10 larvae tested for each genotype in at least two independent experiments. All full data in Figure 7—source data 1.

Figure 7—figure supplement 1
Effects of other polyamines on the cellular nucleic acid-binding protein (CNBP)-dependent locomotor phenotype.

(A) Columns represent the fold difference of putrescine content in dCNBP-depleted larvae grown in absence or presence of 1 mM putrescine. c179GAL4 without putrescine (no UAS), c179GAL4>UASdCNBPRNAi-16283; UASdCNBPRNAi-16284 (2XdCNBPRNAi) with (1 mM put) or without putrescine. **p<0.01, ***p<0.001 with t-test. (B) Box plot representation of the distribution of peristaltic contraction rates performed by third instar larvae of c179GAL4 (no UAS) or by c179GAL4>UASdCNBPRNAi-16283; UASdCNBPRNAi-16284 (2XdCNBPRNAi) with (1 mM spd) or without (no spd) spermidine. The line inside the box indicates the median for each genotype and box boundaries represent the first and third quartiles; whiskers are min and max in the 1.5 interquartile range (****p<0.0001, ordinary one-way ANOVA post hoc Tukey’s test); ≥10 larvae tested for each genotype in at least two independent experiments. Error bars represent SEM. All full data in Figure 7—source data 1.

Figure 7—figure supplement 2
dOdc1 overexpression does not affect dCNBP downregulation.

Immunoblot showing the levels of dCNBP in control larvae (no UAS), compared to larvae interfered for dCNBP (UASdCNBPRNAi-16283; UASdCNBPRNAi-16284; named 2XdCNBPRNAi), or overexpressing dOdc1 (UAS-dOdc1), or to larvae overexpressing dOdc1 and simultaneously interfered for dCNBP (UASdCNBPRNAi-16283; Mef2-GAL4/UASdCNBPRNAi-16284; UAS Odc1/TM6B; named 2XdCNBPRNAi+dOdc1) under the control of the Mef2-GAL4 driver. On the right, the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification) is shown. Tubulin, loading control. A.U., arbitrary unit.

Figure 7—figure supplement 3
dCNBP-depleted flies exhibited an ageing-dependent locomotor dysfunction.

mhcGAL4 (no UAS) or mhcGAL4 > UASdCNBPRNAi-16283; UASdCNBPRNAi-16284 (2XUASdCNBPRNAi) reared at 29°C, male flies were assayed for negative geotaxis measured by the Drosophila activity monitoring (DAM) system at the indicated ages (error bars represent SEM; ***p<0.001; ****p<0.0001, Kruskal-Wallis with post hoc Dunn’s test); ≥15 males tested for each genotype in at least two independent experiments. Full data in Figure 7—source data 1.

Figure 7—figure supplement 4
dCNBP depletion does not cause morphological changes of fly larval muscle tissues.

Muscle morphology and sarcomeric organization of the L2/L3 larval body wall muscles. Confocal images of larval muscles (segment A2; muscle 6/7) form wild-type (WT) controls, UASdCNBPRNAi-16283; UASdCNBPRNAi-16284 (2XdCNBPRNAi) driven by either how24BGAL4 or c179GAL4 as indicated (third instar larvae) or from cnbpk mutant (second instar larvae), stained with DAPI (green) and FITC phalloidin (red); ≥3 larvae have been tested for each genotype in at least two independent experiments.

Cellular nucleic acid-binding protein (CNBP) controls muscle function by regulating polyamine metabolism.

Schematic representation of the mechanism of action of CNBP on muscle function in both Drosophila and humans. CNBP binds ornithine decarboxylase (ODC) mRNA and regulates its translation, leading to increased polyamine content. Lack of CNBP impairs locomotor function through ODC-polyamine downregulation.

Tables

Table 1
Effects of dCNBP silencing using different tissue-specific GAL4 drivers.
Driver lineExpression pattern2XdCNBPRNAi at 29°C2XdCNBPRNAi at 25°C
tubulin-GAL4Constitutive-ubiquitousEmbryonic lethalLarval lethal (third instar)
actin-GAL4Constitutive-ubiquitousEmbryonic lethalLarval lethal (third instar)
elav-GAL4Pan-neuronalNo locom. phenotypeNT
nrv-GAL4Pan-neuronal specific in CNS and PNSNo locom. phenotypeNT
D42-GAL4Motor neuronsNo locom. phenotypeNT
n-syb-GAL4Pan-neuronalNo locom. phenotypeNT
repo-GAL4GliaNo locom. phenotypeNT
69B-GAL4Embryonic epiderm, CNS, and imaginal discsLarval lethal (first instar)Larval lethal. Escapers with locom. defects at 18°C
mhc-GAL4Myosin heavy chain promoterReduced climbing activityNT
Mef2-GAL4Somatic muscle cells, embryonic mesoderm (stages 10–17), embryonic cardioblastEmbryonic lethalSemi-lethal (pupal stage) Escapers with locom. defects
c179-GAL4Embryonic mesoderm and larval musclesReduced larval activityPupal lethal
how24B-GAL4Embryonic mesoderm. Precursors of the somatic muscles, visceral muscles, and cardiac cells. Larval nuclei of muscle fibers.Reduced larval activityPupal lethal
GMR-GAL4Eye imaginal discRetinal degenerationNT
nub-GAL4Wing imaginal discWing size reduction and lost of patterning elementsWing size reduction
5053 GAL4Embryonic longitudinal visceral muscle founder cellsVital and no adult locomotor phenotypeNT
srmd710-GAL4Embryonic and larval tendon cells. No expression in muscle or muscle precursorsVital and no adult locomotor phenotypeNT
Key resources table
Reagent type
(species) or resource
DesignationSource or referenceIdentifiersAdditional information
Genetic reagent (Drosophila melanogaster)actin-GAL4Bloomington25374y[1] w[*]; P{Act5C-GAL4-w}E1/CyO
Genetic reagent (Drosophila melanogaster)tubulin-GAL4Bloomington5138y[1] w[*]; P{w[+mC]=tubP-GAL4}LL7/TM3, Sb[1] Ser[1]
Genetic reagent (Drosophila melanogaster)elav-GAL4Bloomington77894y[1] w[*] P{w[+mC]=elav(FRT.ewg)GAL4.eFeG}1
Genetic reagent (Drosophila melanogaster)nrv-GAL4Bloomington6799w[*]; P{w[+mC]=nrv2-GAL4.S}8
Genetic reagent (Drosophila melanogaster)D42-GAL4Bloomington8816w[*]; P{w[+mW.hs]=GawB}D42
Genetic reagent (Drosophila melanogaster)n-syb-GAL4Bloomington51635y[1] w[*]; P{w[+m*]=nSyb-GAL4.S}3
Genetic reagent (Drosophila melanogaster)repo-GAL4Bloomington7415w[1118]; P{w[+m*]=GAL4} repo/TM3, Sb[1]
Genetic reagent (Drosophila melanogaster)69B-GAL4Bloomington1744w[*]; P{w[+mW.hs]=GawB}69B
Genetic reagent (Drosophila melanogaster)Mhc-GAL4Bloomington38464; w[*]; P{w[+mC]=Mhc-RFP.F3-580}
Genetic reagent (Drosophila melanogaster)Mef2-GAL4Bloomington26882w[*]; Kr[If-1]/CyO, P{w[+mC]=GAL4-Mef2.R}2, P{w[+mC]=UAS-mCD8.mRFP}
Genetic reagent (Drosophila melanogaster)c179-GAL4Bloomington6450w[*]; P{w[+mW.hs]=GawB}c179
Genetic reagent (Drosophila melanogaster)how24B-GAL4Bloomington1767w[*]; P{w[+mW.hs]=GawB}how[24B]
Genetic reagent (Drosophila melanogaster)GMR-GAL4Bloomington9146w[1118]; P{GMR-GAL4.w[-]}2/CyO
Genetic reagent (Drosophila melanogaster)nub-GAL4Bloomington86108w[*]; P{w[nub.PK]=nub-GAL4.K}2
Genetic reagent (Drosophila melanogaster)5053 GAL4Bloomington2702w[*]; P{w[+mW.hs]=GawB}tey[5053A]/TM6B, Tb[+]
Genetic reagent (Drosophila melanogaster)srmd710-GAL4Bloomington26663w[*]; P{w[+mW.hs]=GawB}sr[md710]/TM6B, Tb[1]
Genetic reagent (Drosophila melanogaster)UAS dCNBPRNAiVDRCGD16283CNBP long hairpin on chromosome X
Genetic reagent (Drosophila melanogaster)UAS dCNBPRNAiVDRCGD16284CNBP long hairpin on chromosome 2
Genetic reagent (Drosophila melanogaster)2XUAS dCNBPRNAiAntonucci et al., 2014GD16283+ GD16284-
Genetic reagent (Drosophila melanogaster)dCNBP kKyoto203535y[1] w[67c23]; P{w[+mC]=GSV6}GS11716 / SM1
Genetic reagent (Drosophila melanogaster)UAS dCNBP-HA RNAi resistantThis studyInjection stock #BL 8622
Genetic reagent (Drosophila melanogaster)UAS hCNBP-FLAGThis studyInjection stock #BL 8622
Genetic reagent (Drosophila melanogaster)UAS Odc1RNAiVDRCGD30039Odc1 long hairpin on chromosome 3
Genetic reagent (Drosophila melanogaster)UAS Odc1RNAiVDRCGD30038Odc1 long hairpin on chromosome 2
Genetic reagent
(Drosophila melanogaster)
UAS Odc2RNAiVDRCKK104597Odc2 long hairpin on chromosome 2
Genetic reagent (Drosophila melanogaster)UAS Odc1+Odc2RNAiThis studyGD30038+ KK104597Long hairpin for Odc2 on chromosome 2 and for Odc1 on chromosome 3
Genetic reagent (Drosophila melanogaster)dOdc1 mutantBloomington56103y[1] w[*]; Mi{y[+mDint2]=MIC}Odc1[MI10996]
Genetic reagent (Drosophila melanogaster)UAS dOdc1Gupta et al., 2013--
Antibodyanti-CNBP
(goat)
Abcamab48027, RRID:AB870003WB 1:1000
Antibodyanti-ODC
(rabbit)
ENZOBML-PW8880-0100
RRID:AB_2156495
WB 1:500
Antibodyanti-Actin goatSanta Cruzsc-1616, RRID:AB630836WB 1:3000
Antibodyanti-GFP
(mouse)
Santa Cruzsc-9996, RRID:AB_627695WB 1:3000
Antibodyanti-Vinculin
(mouse)
Santa Cruzsc-73614, RRID:AB_1131294WB 1:3000
Antibodyanti-FLAG-HRPSigmaA8592, RRID:AB_439702WB 1:500
Antibodyanti-CNBP
(mouse)
Agrobio
(this study)
WB 1:1000
Antibodyanti-HA-HRP
(mouse)
Santa Cruzsc-7392, RRID:AB_627809WB 1:2000
Antibodyanti-vibrator (rabbit)Giansanti et al., 2006-WB 1:3000
Sequence-based reagentT7 CNBP FW
Drosophila melanogaster
This studydsRNA primerTAATACGACTCACTATAGGGAG GTCCGGGCGGCGTTGG
Sequence-based reagentT7 CNBP RV
Drosophila melanogaster
This studydsRNA primerTAATACGACTCACTATAGGGAG ATGTGTCCGGTGCGG
Sequence-based reagentdOdc1 Fw
Drosophila melanogaster
This studyPCR primerTGGCAGCGATGACGTAAAGTT
Sequence-based reagentdOdc1 Rv
Drosophila melanogaster
This studyPCR primerTGGTTCGGCGATTATGTGAA
Sequence-based reagentGAPDH Fw
Drosophila melanogaster
This studyPCR primerCCTGGCCAAGGTCATCAATG
Sequence-based reagentGAPDH RvDrosophila melanogasterThis studyPCR primerATGACCTTGCCCACAGCCTT
Sequence-based reagentdOdc1-IRES FWThis studyPCR primerTAAGAATTCCTCGGAAAGATCTCAAC
Sequence-based reagentdOdc1-IRES RWThis studyPCR primerTTAGAATTCACAAGTCGT TGACTGATAAC
Chemical compound, drugDFMOSigma#D193
Commercial assay or kitRevertAid H Minus First Strand cDNA Synthesis kitThermo Fisher ScientificK1632
Chemical compound, drugPutrescineSigma#51799
Chemical compound, drugSpermidineSigma#S2626
Plasmidsplko SCR, plkoSh_cnbpD'Amico et al., 2015
PlasmidsGFPConi et al., 2020
PlasmidshODC-LUCD'Amico et al., 2015
PlasmidsdOdc1-LUCThis study
PlasmidsHA-dCNBPAntonucci et al., 2014
PlasmidsFLAG-hCNBPD'Amico et al., 2015
Cell lineS2DGRCCat# 181, RRID:CVCL_Z992
Cell lineHEK-293TATCCCRL-3216, RRID:CVCL_0063

Additional files

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sonia Coni
  2. Federica A Falconio
  3. Marta Marzullo
  4. Marzia Munafò
  5. Benedetta Zuliani
  6. Federica Mosti
  7. Alessandro Fatica
  8. Zaira Ianniello
  9. Rosa Bordone
  10. Alberto Macone
  11. Enzo Agostinelli
  12. Alessia Perna
  13. Tanja Matkovic
  14. Stephan Sigrist
  15. Gabriella Silvestri
  16. Gianluca Canettieri
  17. Laura Ciapponi
(2021)
Translational control of polyamine metabolism by CNBP is required for Drosophila locomotor function
eLife 10:e69269.
https://doi.org/10.7554/eLife.69269